Per Pfeiffer

Active 1989–2025

102
Papers
18,383
Citations
53
h-index
99
i10-index

Citations

Citations per year for Per Pfeiffer1979: 1 citations1991: 2 citations1992: 1 citations1993: 3 citations1994: 3 citations1995: 3 citations1996: 9 citations1997: 10 citations1998: 9 citations1999: 7 citations2000: 15 citations2001: 12 citations2002: 16 citations2003: 29 citations2004: 17 citations2005: 12 citations2006: 13 citations2007: 8 citations2008: 7 citations2009: 13 citations2010: 19 citations2011: 50 citations2012: 58 citations2013: 82 citations2014: 103 citations2015: 91 citations2016: 87 citations2017: 106 citations2018: 105 citations2019: 538 citations2020: 719 citations2021: 839 citations2022: 571 citations2023: 451 citations2024: 871 citations2025: 476 citations2026: 17 citations1980–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,382 citing papers, 16.5% of this breakdownChina: 947 citing papers, 11.3% of this breakdownItaly: 705 citing papers, 8.4% of this breakdownUnited Kingdom: 469 citing papers, 5.6% of this breakdownGermany: 448 citing papers, 5.4% of this breakdownJapan: 396 citing papers, 4.7% of this breakdownFrance: 387 citing papers, 4.6% of this breakdownSpain: 364 citing papers, 4.4% of this breakdownNetherlands: 322 citing papers, 3.8% of this breakdownBelgium: 197 citing papers, 2.4% of this breakdownAustralia: 180 citing papers, 2.2% of this breakdownSweden: 180 citing papers, 2.2% of this breakdown
0%16.5%Other 28.5%

Fields

  • Medicine77.1%
  • Biochemistry, Genetics and Molecular Biology17.9%
  • Immunology and Microbiology1.2%
  • Engineering0.7%
  • Computer Science0.6%
  • Neuroscience0.5%
  • Other2%

Topics

  • Colorectal Cancer Treatments and Studies11.5%
  • Colorectal Cancer Surgical Treatments5.2%
  • Cancer Genomics and Diagnostics4.6%
  • Genetic factors in colorectal cancer4.4%
  • Cancer Immunotherapy and Biomarkers4.2%
  • Hepatocellular Carcinoma Treatment and Prognosis3.6%
  • Other66.5%

Coauthors

All papers

Open in search
  1. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emile D. Kerver, Sebastiaan Festen, Monique E. van Leerdam, Geerard L. Beets, L. Dewit, C.J.A. Punt, Pieter J. Tanis, Elisabeth D. Geijsen, Peter Nieboer, Wim Bleeker, Albert J. ten Tije, Rogier M. P. H. Crolla, Addy C.M. van de Luijtgaarden, Jan Willem T. Dekker, J.M. Immink, Frank J. Jeurissen, Andreas Marinelli, Heleen M. Ceha, Tanja C. Stam, P. Quarles an Ufford, Willem H. Steup, Alex L.T. Imholz, R.J.I. Bosker, Jasper Bekker, G.J. Creemers, Grard A. P. Nieuwenhuijzen, Henk van den Berg, Wendy M. van der Deure, Roderick F. Schmitz, Johan M. van Rooijen, Annette F. T. Olieman, A.C.M. van den Bergh, Derk Jan A. de Groot, Klaas Havenga, Jannet C. Beukema, Jacob D. de Boer, Peter H.J.M. Veldman, Ester Siemerink, J.W.P. Vanstiphout, B. De Valk, Q. A. J. Eijsbouts, M. Polée, Christiaan Hoff, Annerie Slot, H.W. Kapiteijn, Koen Peeters, Femke P. Peters, P.A. Nijenhuis, Sandra A. Radema, Hans De Wilt, Pètra M. Braam, G.J. Veldhuis, Daniël A. Hess, Tom Rozema, O. Reerink, Daan ten Bokkel Huinink, A. Pronk, Josephine M. I. Vos, Metin Tascilar, Gijs A. Patijn, Christian Kersten, Odd Mjåland, Marianne G. Guren, Arild Nesbakken, Janez Benedik, Ibrahim Edhemović, Vaneja Velenik, Jaume Capdevila, Eloy Espín, Ramón Salazar and 47 more - The Lancet Oncology 2020 cited by 1,622

  2. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael D. Pickard, Janna Christy‐Bittel, Lisa Anderson, Victor Sandor, Josep Tabernero - New England Journal of Medicine 2019 cited by 1,465

  3. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Morteza Aghmesheh, Mauricio Peressoni, Carlos Eduardo Mattos da Cunha Andrade, Fábio Franke, Gustavo R. Alves, Felipe Jose Cruz, Karina Vianna, Maria Marcela Monteiro, Michael J. Raphael, Scott Berry, Raymond Woo-Jun Jang, Ann Tan, Jamil Asselah, Patricio Yañez Weber, Mauricio Mahave, César Sánchez, Pamela Salman, Yuxian Bai, Jin Li, Xiaochun Zhang, Tianshu Liu, Xiaoyan Lin, Shukui Qin, Jianwei Yang, Suxia Luo, Wěi Li, Jieer Ying, Xi Chen, Shan Zeng, Yanli Qu, Lin Yang, Lin Zhao, Ping Chen, Hongming Pan, Enxiao Li, Feng Ye, Jianwei Lu, Xinjun Liang, Qun Zhao, Xianli Yin, Junhe Li, Junhe Li, Guoqing Lv, Shouguo Li, Álvaro Guerrero, Juan Rubiano, M. Fernández, Ray Manneh Kopp, Adrián Guzmán Ramírez, Luis Corrales, Ileana Gonzalez Herrera, Bohuslav Melichar, Tomáš Büchler, Tomáš Svoboda, Radka Obermannová, David Vrána, Jakub Cvek, Per Pfeiffer, Lene Bæksgaard, Mette Yilmaz, Valérie Boige, Daniel López‐Trabada, Christophe Borg, Diane Pannier, Sandrine Hiret, Frédéric Di Fiore, Jean‐Philippe Metges, Dirk Arnold, Uwe M. Martens, Florian Lordick and 128 more - The Lancet Oncology 2023 cited by 622

  4. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Demetris Papamichael, George Pentheroudakis, Per Pfeiffer, Timothy Price, Cornelis J.A. Punt, Jens Ricke, A. Roth, Ramón Salazar, Werner Scheithauer, Hans‐Joachim Schmoll, Josep Tabernero, Julien Taı̈eb, Sabine Tejpar, Harpreet Wasan, Takayuki Yoshino, Aziz Zaanan, Dirk Arnold - Annals of Oncology 2016 cited by 3,449

  5. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , - Annals of Oncology 2023 cited by 511

  6. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Camilla Qvortrup, Tine Plato Hansen, Eric Van Cutsem, Hubert Piessevaux, Diether Lambrechts, Mauro Delorenzi, Sabine Tejpar - The Lancet Oncology 2010 cited by 2,143

  7. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Asif Halimi, Ingunn Hatlevoll, Margareta Heby, Arto Kokkola, Maximilian Kordes, Stina Lindblad, Linda Lundgren, Michael Bau Mortensen, Kim Erlend Mortensen, Jan Persson, Elena Rangelova, Elin Rønne, Oddvar M. Sandvik, Jon Arne Søreide, Caroline Vilhav, Kim Waardal, Johanna Wennerblom, Caroline Williamsson, Sheraz Yaqub - ˜The œLancet. Gastroenterology & hepatology 2024 cited by 206

  8. Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michele Reni, Richard A. Epstein, Paul L. Vasey, Jeremy Shapiro, Matthew Burge, Yu Jo Chua, Marion Harris, Nick Pavlakis, Niall C. Tebbutt, Gerald W. Prager, Christian Dittrich, Friedrich Längle, Kathrin Philipp‐Abbrederis, Richard Greil, Herbert Stöger, Michael Girschikofsky, Thomas Kuehr, Jean–Luc Van Laethem, Stéphanie Laurent, Neesha C. Dhani, Yoo Joung Ko, Scot Dowden, Petr Kavan, Mustapha Édouard Tehfe, Eugen Kubala, Milan Kohoutek, Per Pfeiffer, Mette Yilmaz, Vibeke K. Parner, Tapio Salminen, Leena‐Maija Soveri, Eija Korkeila, Pia Österlund, Julien Taı̈eb, David Tougeron, Pascal Artru, François‐Xavier Caroli‐Bosc, Rosine Guimbaud, Antony Turpin, Thomas Walter, Jean‐Baptiste Bachet, Volker Kunzmann, Florian Kreth, Andreas De Block, Marino Venerito, Helmut Oettle, Meinolf Karthaus, Jörg Trojan, Gunnar Folprecht, Markus M. Lerch, Frank Kullmann, Marcel Reiser, Volker Heinemann, Marcus‐Alexander Wörns, H. Schulz, Benjamin Garlipp, Thomas Yau, Lam Stephen Chan, Balázs Juhász, László Landherr, Tamás Pintér, G. Bodoky, Zsuzsanna Kahán, Raymond McDermott, Derek G. Power, Luca Gianni, Salvatore Siena, Michèle Milella, Alfredo Falcone, Rossana Berardi and 87 more - Journal of Clinical Oncology 2022 cited by 132

  9. Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Per Pfeiffer, Naotoshi Sugimoto, Judit Kocsis, Andràs Csilla, G. Bodoky, Georgina Garnica Jaliffe, Светлана Проценко, Ayman Madi, Elżbieta Wójcik, Baruch Brenner, Gunnar Folprecht, Tomasz Sarosiek, Katriina Peltola, Peter Bono, Hubert Ayala, Giuseppe Aprile, Cardellino Giovanni Gerardo, Fidel David Huitzil Melendez, Alfredo Falcone, Francesco Di Costanzo, Moustapha Tehfe, Laurent Mineur, Pilar Alfonso, Radka Obermannová, Hélène Senellart, Russell Petty, Leslie Samuel, Péter Ács, Maen Hussein, M. Nechaeva, Frans Erdkamp, Elizabeth Won, Johanna C. Bendell, Javier Gállego, Sylvie Lorenzen, Bohuslav Melichar, Miguel Angel Escudero, Denis Pezet, Jean–Marc Phelip, Diego Kaen, James A. Reeves, Federico Longo Muñoz, Srinivasan Madhusudan, Carlo Barone, Luis Fein, Ángel Gómez Villanueva, Mohamed Hebbar, Jana Prausová, L. Visa Turmo, J. Vidal Barrull, Mette Yilmaz, Alex Beny, Hanneke W.M. van Laarhoven, Brian DiCarlo, Taito Esaki, Kazumasa Fujitani, Karen Geboes, Ravit Geva, Shigenori Kadowaki, Stephen Leong, Nozomu Machida, Moses S. Raj, Francisco Javier Ramírez Godinez, Ágnes Ruzsa, Hugo Ford, William Lawler, Nicolas Robert Maisey, Jiřı́ Petera, Einat Shacham‐Shmueli, Isabelle Sinapi and 44 more - The Lancet Oncology 2019 cited by 284

  10. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karin Jordan, Andrey Meshcheryakov, Demetris Papamichail, Per Pfeiffer, Ioannis Souglakos, Serdar Turhal, Andrés Cervantes - Annals of Oncology 2012 cited by 1,534

  11. Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2018 cited by 519

  12. Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew Burge, Sumitra Ananda, Muhammad A. Khattak, Bruce Colwell, Félix Couture, Brandon M. Meyers, Kathryn Towns, Michael B. Sawyer, Lucas Sidéris, Rui‐Hua Xu, Wei Wang, Hongming Pan, Per Pfeiffer, Lars Henrik Jensen, Camilla Qvortrup, Sebastian Stintzing, Dirk Arnold, Sylvie Lorenzen, Stefan Kubicka, Reinhard Depenbusch, Maria Passhak, Ravit Geva, Ayala Hubert, Einat Shacham‐Shmueli, Gleb Kornev, Akihito Kawazoe, Toshiki Masuishi, Atsuo Takashima, Hiroki Hara, Hisato Kawakami, Nozomu Machida, Kentaro Yamazaki, Hisateru Yasui, Akihito Tsuji, Taito Esaki, Kensei Yamaguchi, Tae‐You Kim, Joong Bae Ahn, Myung Ah Lee, Tae Won Kim, Joon Oh Park, Soo Hyun Lee, Р. В. Орлова, V. O. Sarzhevskiy, Marina Sekacheva, S. Tjulandin, Oksana Shirokova, A.I. Iskhakova Iskhakova, A. A. Lebedinets, Paula Jiménez Fonseca, F. Rivera Herrero, Elena Elez Fernandez, Pilar Alfonso, M.J. Gómez Reina, Kun‐Huei Yeh, Hao‐Wei Teng, Tsai Sheng Yang, Hwei‐Ming Wang, Yu‐Min Yeh, Mustafa Özgüroğlu, Mahmut Gumus, Şuayib Yalçın, Bülent Erdoğan, Umut Demırcı, Pınar Gürsoy, Hakan Harputluoğlu, Atakan Demir, Kai‐Keen Shiu, Ewan Brown, Paul J. Ross and 13 more - Journal of Clinical Oncology 2024 cited by 77

  13. TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial

    Authors: , , , , , , , , , - The Lancet Oncology 2020 cited by 231

  14. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jörg Kleeff, Rupaly Pandé, Per Pfeiffer, Daniel Pietrasz, Keith Roberts, António Sá Cunha, Roberto Salvia, Oliver Strobel, Timo Tarvainen, Patrick M. Bossuyt, Hanneke W.M. van Laarhoven, Johanna W. Wilmink, Bas Groot Koerkamp, Marc G. Besselink - JAMA Oncology 2020 cited by 136

  15. Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark I. van Berge Henegouwen, Maarten C.C.M. Hulshof, Jolanda van Dieren, Marieke A. Vollebergh, Johanna W. van Sandick, Paul M. Jeene, C.T. Muijs, Marije Slingerland, Francine E.M. Voncken, Henk H. Hartgrink, Geert-Jan Creemers, Maurice J.C. van der Sangen, Grard A. P. Nieuwenhuijzen, Maaike Berbée, Marcel Verheij, Bas P. L. Wijnhoven, Laurens V. Beerepoot, Nadia Haj Mohammad, Stella Mook, Jelle P. Ruurda, Piotr Kołodziejczyk, Wojciech Polkowski, Lucjan Wyrwicz, María Alsina, Manuel Pera, Tania Fleitas, Andrés Cervantes, Magnus Nilsson, Stefan Mönig, Dorothea Wagner, Matthias Gückenberger, Ewen A. Griffiths, Elizabeth Smyth, George B. Hanna, Sheraz R. Markar, M. Asif Chaudry, M. Hawkins, Edward Cheong, Richard van Hillegersberg, Peter S.N. van Rossum, Tom Rozema, Joos Heisterkamp, Markus Schaefer, E.M. Ozsahin, Jacco J. de Haan, Jan Willem van den Berg, Frédéric Duprez, Eduard Callebout, Elke Van Daele, Ulrich Hacker, Albrecht Hoffmeister, Thomas Kuhnt, Timm Denecke, Regine Kluge, Gerald W. Prager, Aysegül Ilhan‐Mutlu, Dajana Cuicchi, Andrea Ardizzoni, Camiel Rosman, Elske C. Gootjes, Heidi Rütten, Francesco Puccetti, Stefano Cascinu, N. Slim, Maria Eugenia Barrios, Maria Carmen Fernandez, Roberto Martí-Oriol, Marisol Huerta Alvaro, Almudena Vera, E. Jordá and 10 more - European Journal of Cancer 2023 cited by 53

  16. Home parenteral nutrition increases fat free mass in patients with incurable gastrointestinal cancer. Results of a randomized controlled trial

    Authors: , , , - Clinical Nutrition 2017 cited by 77

  17. Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 530

  18. Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?

    Authors: , , , , , , , - Annals of Surgery 2014 cited by 207

  19. Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study

    Authors: , , , , , , , - Annals of Surgical Oncology 2023 cited by 47

  20. Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance

    Authors: , , , , , , , , , , , , , , , , , , , , , - Molecular Oncology 2015 cited by 139

  21. Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

    Authors: , , , , , , , , , , , - Oncotarget 2016 cited by 80

  22. Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review

    Authors: , , , - BMC Cancer 2020 cited by 49

  23. Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Johanna W. van Sandick, C.T. Muijs, Marije Slingerland, Grard A. P. Nieuwenhuijzen, Bas P. L. Wijnhoven, Laurens V. Beerepoot, Piotr Kołodziejczyk, Wojciech Polkowski, María Alsina, Manuel Pera, Tania Fleitas, Magnus Nilsson, Matthias Gückenberger, Stefan Mönig, Dorothea Wagner, Lucjan Wyrwicz, Maaike Berbée, Ines Gockel, Florian Lordick, Ewen A. Griffiths, Marcel Verheij, Peter S.N. van Rossum, Hanneke W.M. van Laarhoven, Camiel Rosman, H.J.T. Rutten, Elske C. Gootjes, Francine E.M. Vonken, Jolanda M. van Dieren, Marieke A. Vollebergh, Maurice van der Sangen, Geert‐Jan Creemers, Thomas Zander, Hans Schlößer, Stefano Cascinu, Elena Mazza, Roberto Nicoletti, Anna Damascelli, N. Slim, Paolo Passoni, Andrea Cossu, Francesco Puccetti, Lavinia Barbieri, Lorella Fanti, Francesco Azzolini, Federico Ventoruzzo, Antoni Szczepanik, Laura Visa, A. Reig, Tom Roques, Mark Harrison, Bogumiła Ciseł, Agnieszka Pikuła, Magdalena Skórzewska, Hanne Vanommeslaeghe, Elke Van Daele, Piet Pattyn, Karen Geboes, Eduard Callebout, Suzane Ribeiro, Peter van Duijvendijk, Cathrien Tromp, Meindert N. Sosef, Fabienne Warmerdam, Joos Heisterkamp, Joos Heisterkamp, Almudena Vera, E. Jordá, Fernando López‐Mozos, María‐Carmen Fernández‐Moreno, Maria Eugenia Barrios-Carvajal and 21 more - European Journal of Cancer 2022 cited by 42

  24. Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data

    Authors: , , - Cancers 2021 cited by 39